Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with an already high prevalence (7.7% in a Dutch reference population >55 years), and this will further increase over the… Click to show full abstract
Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with an already high prevalence (7.7% in a Dutch reference population >55 years), and this will further increase over the next decades.1, 2 AF is associated with a reduced quality of life and an increased morbidity and mortality which leads to high health-related expenditures.3 The overall management of AF is complex and needs to be tailored to the individual patient.1 However, adherence to evidence-based management guidelines is suboptimal in daily practice throughout Europe.4.
               
Click one of the above tabs to view related content.